Medilines Distributors Incorporated (PSE:MEDIC)
Philippines
· Delayed Price · Currency is PHP 0.2900
+0.0144 (5.24%)
At close: Jul 1, 2025
Medilines Distributors Income Statement
Financials in millions PHP. Fiscal year is January - December.
Millions PHP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| 1,336 | 1,416 | 679.88 | 1,965 | 1,585 | 1,467 | Upgrade
| |
Revenue Growth (YoY) | 22.04% | 108.29% | -65.40% | 23.96% | 8.07% | 9.94% | Upgrade
|
Cost of Revenue | 901.41 | 1,012 | 436.96 | 1,581 | 1,253 | 1,223 | Upgrade
|
Gross Profit | 434.66 | 403.87 | 242.92 | 383.33 | 332.16 | 243.67 | Upgrade
|
Selling, General & Admin | 175.53 | 175.97 | 138.06 | 123.6 | 101.65 | 72.44 | Upgrade
|
Operating Expenses | 229.32 | 229.77 | 137.77 | 124.8 | 126.12 | 81.75 | Upgrade
|
Operating Income | 205.34 | 174.1 | 105.15 | 258.52 | 206.04 | 161.92 | Upgrade
|
Interest Expense | -25.69 | -16.85 | -13.52 | -9.2 | -47.4 | -31.05 | Upgrade
|
Interest & Investment Income | 2.37 | 0.08 | 0.1 | 0.25 | 25.6 | 25.2 | Upgrade
|
Currency Exchange Gain (Loss) | -4.25 | -1.49 | -13.38 | -23.44 | -0.85 | -3.46 | Upgrade
|
Other Non Operating Income (Expenses) | 18.63 | 17.15 | 19.14 | 30.77 | -1.24 | -5.37 | Upgrade
|
EBT Excluding Unusual Items | 196.41 | 172.99 | 97.5 | 256.9 | 182.15 | 147.23 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | - | 28.89 | - | Upgrade
|
Other Unusual Items | - | - | - | - | -1.17 | - | Upgrade
|
Pretax Income | 196.41 | 172.99 | 97.5 | 256.9 | 209.88 | 147.23 | Upgrade
|
Income Tax Expense | 49.26 | 43.25 | 25.03 | 64.93 | 40.24 | 44.17 | Upgrade
|
Net Income | 147.15 | 129.74 | 72.46 | 191.97 | 169.63 | 103.06 | Upgrade
|
Net Income to Common | 147.15 | 129.74 | 72.46 | 191.97 | 169.63 | 103.06 | Upgrade
|
Net Income Growth | 22.76% | 79.05% | -62.25% | 13.17% | 64.59% | 54.65% | Upgrade
|
Shares Outstanding (Basic) | 2,928 | 2,747 | 2,748 | 2,750 | 1,896 | 1,600 | Upgrade
|
Shares Outstanding (Diluted) | 2,928 | 2,747 | 2,748 | 2,750 | 1,896 | 1,600 | Upgrade
|
Shares Change (YoY) | 9.13% | -0.05% | -0.08% | 45.05% | 18.49% | 251.80% | Upgrade
|
EPS (Basic) | 0.05 | 0.05 | 0.03 | 0.07 | 0.09 | 0.06 | Upgrade
|
EPS (Diluted) | 0.05 | 0.05 | 0.03 | 0.07 | 0.09 | 0.06 | Upgrade
|
EPS Growth | 10.53% | 79.14% | -62.22% | -21.98% | 38.91% | -56.04% | Upgrade
|
Free Cash Flow | 9.96 | 38.9 | -194.82 | -335.34 | 269.85 | -681.52 | Upgrade
|
Free Cash Flow Per Share | 0.00 | 0.01 | -0.07 | -0.12 | 0.14 | -0.43 | Upgrade
|
Dividend Per Share | - | - | 0.003 | 0.010 | 0.006 | 0.159 | Upgrade
|
Dividend Growth | - | - | -75.19% | 71.80% | -96.17% | - | Upgrade
|
Gross Margin | 32.53% | 28.52% | 35.73% | 19.51% | 20.96% | 16.61% | Upgrade
|
Operating Margin | 15.37% | 12.29% | 15.47% | 13.16% | 13.00% | 11.04% | Upgrade
|
Profit Margin | 11.01% | 9.16% | 10.66% | 9.77% | 10.70% | 7.03% | Upgrade
|
Free Cash Flow Margin | 0.75% | 2.75% | -28.66% | -17.07% | 17.03% | -46.47% | Upgrade
|
EBITDA | 217.77 | 186.01 | 118 | 268.08 | 216.18 | 172.8 | Upgrade
|
EBITDA Margin | 16.30% | 13.13% | 17.36% | 13.64% | 13.64% | 11.78% | Upgrade
|
D&A For EBITDA | 12.42 | 11.91 | 12.85 | 9.55 | 10.14 | 10.88 | Upgrade
|
EBIT | 205.34 | 174.1 | 105.15 | 258.52 | 206.04 | 161.92 | Upgrade
|
EBIT Margin | 15.37% | 12.29% | 15.47% | 13.16% | 13.00% | 11.04% | Upgrade
|
Effective Tax Rate | 25.08% | 25.00% | 25.68% | 25.27% | 19.18% | 30.00% | Upgrade
|
Advertising Expenses | - | 0.22 | 0.28 | 1.09 | 0.63 | - | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.